TCIM
ALXN

TIAA CREF Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

TIAA CREF Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$450M Buy
3,328,824
+1,401,686
+73% +$189M 0.32% 61
2018
Q4 		$188M Sell
1,927,138
-476,998
-20% -$46.4M 0.15% 142
2018
Q3 		$334M Sell
2,404,136
-221,989
-8% -$30.9M 0.22% 99
2018
Q2 		$326M Sell
2,626,125
-879,659
-25% -$109M 0.22% 98
2018
Q1 		$391M Sell
3,505,784
-331,135
-9% -$36.9M 0.26% 83
2017
Q4 		$459M Buy
3,836,919
+414,969
+12% +$49.6M 0.3% 68
2017
Q3 		$480M Buy
3,421,950
+201,989
+6% +$28.3M 0.33% 64
2017
Q2 		$392M Buy
3,219,961
+955,578
+42% +$116M 0.28% 79
2017
Q1 		$275M Sell
2,264,383
-292,305
-11% -$35.4M 0.2% 104
2016
Q4 		$313M Buy
2,556,688
+81,702
+3% +$10M 0.23% 91
2016
Q3 		$303K Sell
2,474,986
-477,219
-16% -$58.5K 0.19% 107
2016
Q2 		$345M Buy
2,952,205
+762,010
+35% +$89M 0.26% 81
2016
Q1 		$305M Sell
2,190,195
-174,586
-7% -$24.3M 0.23% 93
2015
Q4 		$451M Buy
2,364,781
+310,630
+15% +$59.3M 0.34% 65
2015
Q3 		$321M Sell
2,054,151
-1,036,671
-34% -$162M 0.25% 81
2015
Q2 		$559M Buy
3,090,822
+730,651
+31% +$132M 0.4% 50
2015
Q1 		$409M Sell
2,360,171
-92,922
-4% -$16.1M 0.28% 72
2014
Q4 		$454M Buy
2,453,093
+414,497
+20% +$76.7M 0.32% 62
2014
Q3 		$338M Buy
2,038,596
+47,551
+2% +$7.88M 0.24% 85
2014
Q2 		$311M Buy
1,991,045
+238,999
+14% +$37.3M 0.22% 101
2014
Q1 		$267M Sell
1,752,046
-1,041,224
-37% -$158M 0.19% 110
2013
Q4 		$372M Sell
2,793,270
-394,715
-12% -$52.5M 0.27% 81
2013
Q3 		$370M Buy
3,187,985
+511,703
+19% +$59.4M 0.29% 69
2013
Q2 		$247M Buy
+2,676,282
New +$247M 0.2% 101